Testing new HIV vaccines for safety and effectiveness
Official title: “GLP Toxicology Study for Adjuvanted HIV-1 Immunogen Vaccine Candidates
Funded at Sri International · NIH-11169231 · Data updated 2026-11-12
This study is working on new vaccines for HIV to make sure they are safe and can help your body fight the virus, with the goal of offering better options for preventing HIV in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | August 1, 2024 |
| Project end | February 1, 2026 |
| Funding year | 2024 |
| Award (this year) | $714,629 |
| NIH project number | 75N93022D00007-0-759302400001-1 |
| Project ID | NIH-11169231 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be individuals at risk for HIV or those interested in HIV prevention.
✕Less likely to help
Patients who are already living with HIV or those who do not have a risk of exposure may not benefit from this research.
What this research studies
This research focuses on the development and testing of new vaccine candidates for HIV. It involves preclinical and translational studies to ensure these vaccines are safe and can generate an immune response. The program will support various stages of vaccine development, including small-scale production and preclinical testing, ultimately leading to clinical trials. Patients may benefit from advancements in HIV prevention through improved vaccine options.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines for preventing HIV infection.
How similar studies have gone: Previous research in vaccine development for HIV has shown promise, but this approach may offer novel advancements.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Related research
Other NIH-funded projects on the same topics.
-
ABCD-USA Consortium: A large, long-term study tracking brain development in youth
A large, long-term study at multiple sites is following thousands of children and teens to understand how their brains grow and relate to health, behavior, and environment.
-
BioCyc, MetaCyc, and EcoCyc knowledge bases expansion with AI assistance
Aims to speed up and improve the BioCyc family of knowledge bases that map genomes and metabolic pathways, using AI to accelerate data curation for researchers who study microbes and metabolism.
-
Tracking HIV, alcohol use, and brain aging with MRI
Aging people living with HIV who also have alcohol use disorder are being studied to understand how brain changes relate to balance, movement, and thinking over time using MRI.
-
NCANDA-SRI: Studying how adolescent drinking affects brain development and adulthood
A long-term study at SRI International follows teens who started drinking to see how it may change brain development and risk for alcohol use disorders as they grow into adults.
-
Brain changes behind thinking and movement problems in older people with HIV and Parkinson's
This project looks at brain changes that may explain why older people living with HIV sometimes have thinking and movement problems similar to Parkinson's.
-
ABCD brain and child development project at SRI
Following children who were 9–10 years old to learn how their brains, health, and behavior change from childhood into young adulthood.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.